SARS-CoV-2 3CLpro-IN-1

SARS-CoV-2 3CLpro-IN-1

• CAS Number: 2757970-20-8
• UNSPSC Description: SARS-CoV-2 3CLpro-IN-1 (Compound 14c) is a potent inhibitor of SARS-CoV-2 3CLpro. 3CLpro (main coronaviruses cysteine-protease) has been identified as a promising target for the development of antiviral agents. SARS-CoV-2 3CLpro-IN-1 has the potential for the research of infection diseases[1].
• Target Antigen: SARS-CoV
• Type: Reference compound
• Related Pathways: Anti-infection
• Applications: COVID-19-anti-virus
• Field of Research: Infection
• Assay Protocol: https://www.medchemexpress.com/sars-cov-2-3clpro-in-1.html
• Solubility: 10 mM in DMSO
• Smiles: O=C(NCCC1=CC=CC(Cl)=C1)C(N(C2=CC=C(C(C)(C)C)C=C2)S(=O)(C=C)=O)C3=CC=CN=C3
• Molecular Weight: 512.06
• References & Citations: [1]Stille JK, et al. Design, synthesis and in vitro evaluation of novel SARS-CoV-2 3CLpro covalent inhibitors. Eur J Med Chem. 2022 Feb 5;229:114046.
• Shipping Conditions: Room temperature
• Clinical Information: No Development Reported